Minimal Residual Disease Predicts Outcome at Two Time Points in Myeloma
Cancer Discovery
|April 15, 2022
Abstract:
Minimal residual disease (MRD) at two time points after transplantation in myeloma is a predictor of survival.
Abstract:
Minimal residual disease (MRD) at two time points after transplantation in myeloma is a predictor of survival.